FDA clears RF (radiofrequency) ablation pen for cardiac use
This article was originally published in Clinica
The US FDA has cleared for sale Medtronic's radiofrequency (RF)-based, pen-like device for the general ablation of cardiac tissue.
You may also be interested in...
The FDA’s OPQ touts approval of sixth and seventh continuously manufactured drugs and quicker delivery of inspection results in latest annual report.
No device-related warning letters were released by the US FDA the week of 19 February.
Complex generics and value added medicines share common challenges on harmonization of regulation, lack of incentives and clarity of guidelines, heard delegates to Medicines for Europe’s Regulatory & Scientific Affairs conference.